Target Price | $45.90 |
Price | $41.35 |
Potential |
11.00%
register free of charge
|
Number of Estimates | 20 |
20 Analysts have issued a price target Exelixis, Inc. 2026 .
The average Exelixis, Inc. target price is $45.90.
This is
11.00%
register free of charge
$63.00
52.36%
register free of charge
$36.36
12.07%
register free of charge
|
|
A rating was issued by 26 analysts: 16 Analysts recommend Exelixis, Inc. to buy, 10 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Exelixis, Inc. stock has an average upside potential 2026 of
11.00%
register free of charge
|
Jan '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion $ | 2.17 | 2.67 |
22.88% | ||
EBITDA Margin | 33.14% | 34.08% |
2.83% | ||
Net Margin | 24.04% | 29.57% |
23.02% |
21 Analysts have issued a sales forecast Exelixis, Inc. 2026 . The average Exelixis, Inc. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Exelixis, Inc. EBITDA forecast 2026. The average Exelixis, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Exelixis, Inc. Analysts have issued a net profit forecast 2026. The average Exelixis, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jan '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.76 | 2.92 |
65.91% | ||
P/E | 14.17 | |
EV/Sales | 3.88 |
22 Analysts have issued a Exelixis, Inc. forecast for earnings per share. The average Exelixis, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Locked
➜
Locked
|
Locked | Sep 17 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Sep 17 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | Sep 17 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
UBS |
Locked
➜
Locked
|
Locked | Jul 30 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Jul 29 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 29 2025 |
Analyst Rating | Date |
---|---|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Sep 17 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Sep 17 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
Sep 17 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 12 2025 |
Locked
UBS:
Locked
➜
Locked
|
Jul 30 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Jul 29 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 29 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.